Article
The Current Status of Drug-resistant Aspergillus.
Medical mycology journal - 1 Jan 2016
Tashiro Masato, Izumikawa Koichi
Abstract excerpt
Aspergillus spp. are important fungi because of the high mortality associated with aspergillosis. However, we have only three classes of anti-aspergillus drugs available; and only two drugs, itraconazole (ITCZ) and voriconazole (VRCZ), are available as oral agents in Japan. If azole-resistant Aspergillus causes chronic aspergillosis, we cannot treat such patients with oral azoles on an outpatient basis. As is the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
